Artykuły w czasopismach na temat „Conference (1926 : Philadelphia, Pa.)”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Conference (1926 : Philadelphia, Pa.)”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
O'Keefe, Thomas, Christina Yau, Emma Iaconetti, Eliza Jeong, Case Brabham, Paul Kim, Joseph McGuire i in. "Abstract PR008: Duration of endocrine treatment for DCIS impacts second events: Insights from a large registry of cases at two academic medical centers". Cancer Prevention Research 15, nr 12_Supplement_1 (1.12.2022): PR008. http://dx.doi.org/10.1158/1940-6215.dcis22-pr008.
Pełny tekst źródłaSmith, Randall S., Andrea Jewell, Evrosina Isaac i Jennifer M. Rohan. "Abstract B090: Relationship between medication adherence, psychosocial risk, and sociodemographic characteristics in pediatric cancer". Cancer Epidemiology, Biomarkers & Prevention 32, nr 1_Supplement (1.01.2023): B090. http://dx.doi.org/10.1158/1538-7755.disp22-b090.
Pełny tekst źródłaCarter, Brian J., Tzuan A. Chen, Dalnim Cho, Lorna H. McNeill, Shahnjayla K. Connors i Lorraine R. Reitzel. "Abstract A099: Black church-goers who most recently sought cancer information from certain sources are less likely to have ever undergone colorectal cancer screening and thus less likely to benefit from early detection". Cancer Epidemiology, Biomarkers & Prevention 32, nr 1_Supplement (1.01.2023): A099. http://dx.doi.org/10.1158/1538-7755.disp22-a099.
Pełny tekst źródłaLalonde, Chloe S., Jeffrey M. Switchenko, Madhusmita Behera, Mehmet A. Bilen, Taofeek K. Owonikoko, Colleen M. Lewis, Elise Hitron i in. "Abstract B085: Shifting sociodemographic characteristics of a phase 1 oncology clinical trial population at an NCI-designated Comprehensive Cancer Center in the Southeast in comparison to its catchment area". Cancer Epidemiology, Biomarkers & Prevention 32, nr 1_Supplement (1.01.2023): B085. http://dx.doi.org/10.1158/1538-7755.disp22-b085.
Pełny tekst źródłaTelles, Victoria M., Mateo Banegas i David Strong. "Abstract B131: Social drivers of adverse health outcomes among cancer survivors". Cancer Epidemiology, Biomarkers & Prevention 32, nr 12_Supplement (1.12.2023): B131. http://dx.doi.org/10.1158/1538-7755.disp23-b131.
Pełny tekst źródłaVasthu, Durango. "Global Supply Chain Management Conference". International Journal of Risk and Contingency Management 1, nr 1 (styczeń 2012): 64–65. http://dx.doi.org/10.4018/ijrcm.2012010105.
Pełny tekst źródłaJohnson, Wenora Y. "Abstract IA002: How patient advocates can make a difference in their research advocacy efforts and contributions and why it's important". Cancer Epidemiology, Biomarkers & Prevention 32, nr 1_Supplement (1.01.2023): IA002. http://dx.doi.org/10.1158/1538-7755.disp22-ia002.
Pełny tekst źródłaDrage, Michael G. "Abstract IA005: Artificial intelligence for breast pathology: Challenges and opportunities (and more challenges!)". Cancer Prevention Research 15, nr 12_Supplement_1 (1.12.2022): IA005. http://dx.doi.org/10.1158/1940-6215.dcis22-ia005.
Pełny tekst źródłaAshour, Ahmed M., Amro M. Al-Omari, Mohammad S. Bani Amer i Zaid R. Kamal. "Abstract A010: Insights into the Impact of Fanconi Anemia Repair Genes on Immunotherapy Response in Solid Tumors". Cancer Research 84, nr 1_Supplement (9.01.2024): A010. http://dx.doi.org/10.1158/1538-7445.dnarepair24-a010.
Pełny tekst źródłaSharma, Hari, Stephen Skaper i Aruna Sharma. "Conference Report: 7th Clinical Trials on Alzheimer’s Disease Annual Conference, Philadelphia, PA, USA Nov 20-22, 2014". CNS & Neurological Disorders - Drug Targets 14, nr 1 (1.02.2015): 7–10. http://dx.doi.org/10.2174/1871527314666150130155536.
Pełny tekst źródłaLeighow, Scott M., Haider Inam i Justin R. Pritchard. "Abstract B007: Design and construction of evolutionary-guided "selection gene drive" therapy". Cancer Research 82, nr 10_Supplement (15.05.2022): B007. http://dx.doi.org/10.1158/1538-7445.evodyn22-b007.
Pełny tekst źródłaDawson, Michelle R., i Deepraj Ghosh. "Abstract A002: Physical and metabolic aspects of therapy induced senescence and polyploidy in an evolving tumor microenvironment". Cancer Research 83, nr 2_Supplement_1 (15.01.2023): A002. http://dx.doi.org/10.1158/1538-7445.agca22-a002.
Pełny tekst źródłaWatson, Nyeema, i Jennifer Johnson Kebea. "All In: The Urban Mission". Metropolitan Universities 31, nr 2 (20.07.2020): 3–6. http://dx.doi.org/10.18060/24223.
Pełny tekst źródłaHockings, Helen, Michelle Lockley, Trevor Graham, Eszter Lakatos i Weini Huang. "Abstract B001: Developing adaptive therapy to suppress the evolution of treatment resistance in high-grade serous ovarian cancer". Cancer Research 82, nr 10_Supplement (15.05.2022): B001. http://dx.doi.org/10.1158/1538-7445.evodyn22-b001.
Pełny tekst źródłade Aragao Mendes, Adrianna Amaral, Hans Liu, Juhyung Woo, Kaushal Asrani, Avi Rosenberg, Pedram Argani i Tamara Lotan. "Abstract A019: Development and characterization of novel pre-clinical models of SFPQ-TFE3-driven renal cell carcinoma". Cancer Research 83, nr 16_Supplement (15.08.2023): A019. http://dx.doi.org/10.1158/1538-7445.kidney23-a019.
Pełny tekst źródłaZhuang, Xueqian, Simon Joost, Qing Wang, Melissa Blum, Selena Ding, Zhuxuan Li, Yingqian Zhan, Richard Koche, Emily Wong i Tuomas Tammela. "Abstract B019: Aging-induced reprogramming of the cell of origin defines lung cancer evolution". Cancer Research 83, nr 2_Supplement_1 (15.01.2023): B019. http://dx.doi.org/10.1158/1538-7445.agca22-b019.
Pełny tekst źródłaZhakula-Kostadinova, Nadja, Sejal Jain, Laura Byron, Matthew L. Meyerson i Alison M. Taylor. "Abstract B018: Investigating vulnerabilities associated with chromosome arm aneuploidy in cancer". Molecular Cancer Therapeutics 23, nr 6_Supplement (10.06.2024): B018. http://dx.doi.org/10.1158/1538-8514.synthleth24-b018.
Pełny tekst źródłaAlfaro-Murillo, Jorge A., Krishna Dasari i Jeffrey P. Townsend. "Abstract B011: Detecting pairwise and higher-order antagonistic epistatic effects among somatic cancer genotypes to discover synthetic lethality". Molecular Cancer Therapeutics 23, nr 6_Supplement (10.06.2024): B011. http://dx.doi.org/10.1158/1538-8514.synthleth24-b011.
Pełny tekst źródłaAndersson, Natalie, Adriana Mañas Nuñez, Kristina Aaltonen, Karin Hansson, Alexandra Seger, Katarzyna Radke, Javanshir Esfandyari, Daniel Bexell i David Gisselsson. "Abstract A011: Deciphering clonal evolution under chemotherapy in high-risk neuroblastoma using patient derived models". Cancer Research 82, nr 10_Supplement (15.05.2022): A011. http://dx.doi.org/10.1158/1538-7445.evodyn22-a011.
Pełny tekst źródłaAvdieiev, Stanislav, Leticia Tordesillas, Omar Chavez Chiang, Zhihua Chen, Luiza Silva Simoes, Y. Ann Chen, Noemi Andor i in. "Abstract A017: In vivo tracking of clonal dynamics during UV-induced skin carcinogenesis". Cancer Research 82, nr 10_Supplement (15.05.2022): A017. http://dx.doi.org/10.1158/1538-7445.evodyn22-a017.
Pełny tekst źródłaGardner, Andrea, Lan Zheng, Kennedy Howland, Chisom Iloegbunam, Patrik Barrera, Carolina De Santiago i Amy Brock. "Abstract B017: Homotypic cell-cell fusion in TNBC cells downregulates cancer testis antigen MAGEC2 and increases therapeutic sensitivity to paclitaxel and doxorubicin". Cancer Research 82, nr 10_Supplement (15.05.2022): B017. http://dx.doi.org/10.1158/1538-7445.evodyn22-b017.
Pełny tekst źródłaGatenbee, Chandler D., Ann-Marie Baker, Ryan O. Schenck, Maximilian Strobl, Jeffrey West, Mark Robertson-Tessi, Trevor A. Graham i Alexander R. A. Anderson. "Abstract B033: Immunosuppressive niche engineering at the onset of human colorectal cancer". Cancer Research 82, nr 10_Supplement (15.05.2022): B033. http://dx.doi.org/10.1158/1538-7445.evodyn22-b033.
Pełny tekst źródłaGiersch, Rachael M., Marisa A. Yonemitsu, Samuel F. M. Hart i Michael J. Metzger. "Abstract A023: Progression and regression dynamics of bivalve transmissible neoplasia in the soft-shell clam (Mya arenaria) after both natural and experimental exposure". Cancer Research 82, nr 10_Supplement (15.05.2022): A023. http://dx.doi.org/10.1158/1538-7445.evodyn22-a023.
Pełny tekst źródłaBraxton, Alicia M., Ashley Kiemen, Rachel Karchin, Yuchen Jiao, Pei-Hsun Wu, Ralph H. Hruban, Denis Wirtz i Laura D. Wood. "Abstract B027: Three-dimensional genomic analysis of human pancreatic intraepithelial neoplasia (PanIN) reveals striking multifocality and genetic heterogeneity". Cancer Research 82, nr 22_Supplement (15.11.2022): B027. http://dx.doi.org/10.1158/1538-7445.panca22-b027.
Pełny tekst źródłaMason, Frank M., Anteneh T. Tebeje, Emily S. Kounlavong, Rashmi Dahiya, Logan Vlach, Tiffany Guess, Ruhee Dere i in. "Abstract B016: SETD2 safeguards the genome against isochromosome formation". Cancer Research 83, nr 16_Supplement (15.08.2023): B016. http://dx.doi.org/10.1158/1538-7445.kidney23-b016.
Pełny tekst źródłaMiyano, Masaru, Rosalyn W. Sayaman, Parijat Senapati, Stefan Hinz, Victoria E. Seewaldt, Dustin Schones i Mark A. LaBarge. "Abstract A003: Integrating noise into a signal: Luminal epithelial cells integrate variable responses to aging into stereotypical changes that underlie breast cancer susceptibility". Cancer Research 83, nr 2_Supplement_1 (15.01.2023): A003. http://dx.doi.org/10.1158/1538-7445.agca22-a003.
Pełny tekst źródłaModiano, Jaime F., Ashley J. Schulte, Taylor A. DaPauw, Ali Khammanivong, Jong H. Kim, Aaron L. Sarver, Gary R. Cutter, Eric Lindquist i Kelly M. Makielski. "Abstract A004: Identification and characterization of the cancer permissive environment in companion dogs". Cancer Research 83, nr 2_Supplement_1 (15.01.2023): A004. http://dx.doi.org/10.1158/1538-7445.agca22-a004.
Pełny tekst źródłaZhang, Yuxia, Virginia Ojeda, Xiaobo Wang, Ken Dunner, Filippo Giancotti, Hao Zhou, Jonathan Hernandez i Steven Q. Xu. "Abstract A029: Merlin/NF2 inhibits pancreatic cancer metastasis by activation of AMPK-dependent autophagic degradation of p62". Cancer Research 84, nr 3_Supplement_2 (1.02.2024): A029. http://dx.doi.org/10.1158/1538-7445.canevol23-a029.
Pełny tekst źródłaOlsen, Sarah Naomi, Bryn Anderson, Charles Hatton, Rinath Jeselsohn, Myles Brown, Eneda Toska i Scott Armstrong. "Abstract A025: KAT6A/B and Menin-MLL complexes coordinately regulate estrogen receptor-driven gene expression programs in breast cancer". Molecular Cancer Therapeutics 23, nr 6_Supplement (10.06.2024): A025. http://dx.doi.org/10.1158/1538-8514.synthleth24-a025.
Pełny tekst źródłaDeng, Qiyun, Mehdi Amiri, Anastasija Ana Piric, Yasaman Bagherian, Zilan Li, Sidong Huang, Michael Pollak i Nahum Sonenberg. "Abstract A014: Inhibiting eIF4E phosphorylation sensitizes triple-negative breast cancer to CDK4/6 inhibition". Molecular Cancer Therapeutics 23, nr 6_Supplement (10.06.2024): A014. http://dx.doi.org/10.1158/1538-8514.synthleth24-a014.
Pełny tekst źródłaChen, Richard J., Drew F. K. Williamson, Ming Y. Lu, Tiffany Y. Chen, Jana Lipkova, Muhammad Shaban i Faisal Mahmood. "Abstract A007: Racial disparities bias oncology AI models". Cancer Epidemiology, Biomarkers & Prevention 32, nr 1_Supplement (1.01.2023): A007. http://dx.doi.org/10.1158/1538-7755.disp22-a007.
Pełny tekst źródłaShokat, Kevan M. "Abstract IA08: Direct covalent inhibitors of mutant K-Ras". Molecular Cancer Research 21, nr 5_Supplement (1.05.2023): IA08. http://dx.doi.org/10.1158/1557-3125.ras23-ia08.
Pełny tekst źródłaHahn, William C. "Abstract IA25: Systematic interrogation of KRAS function". Molecular Cancer Research 21, nr 5_Supplement (1.05.2023): IA25. http://dx.doi.org/10.1158/1557-3125.ras23-ia25.
Pełny tekst źródłaLahtinen, Alexandra, Kari Lavikka, Yilin Li, Sanaz Jamalzadeh, Anni Virtanen, Rainer Lehtonen, Olli Carpén i in. "Abstract A010: Integration of clonal composition and tumor heterogeneity reveals novel evolutionary states and intervention targets in ovarian cancer". Cancer Research 82, nr 10_Supplement (15.05.2022): A010. http://dx.doi.org/10.1158/1538-7445.evodyn22-a010.
Pełny tekst źródłaHirosue, Shoko, Jianfeng Ge, Leticia Castillon, Paulo Rodrigues, Dóra Bihary, Alyson Speed, Ludovic Wesolowski i in. "Abstract A015: Injury-associated transcriptional state transitions in early renal carcinogenesis". Cancer Research 83, nr 16_Supplement (15.08.2023): A015. http://dx.doi.org/10.1158/1538-7445.kidney23-a015.
Pełny tekst źródłaChen, Guangbo, Hong Zheng, Yael Rosenberg-Hasson, Saron Araya, Cindy Padilla, Kavita Sarin, Cornelia L. Dekker i in. "Abstract A014: Cytokines surge in the blood years prior to a cancer diagnosis in elderly individuals". Cancer Research 83, nr 2_Supplement_1 (15.01.2023): A014. http://dx.doi.org/10.1158/1538-7445.agca22-a014.
Pełny tekst źródłaLi, Peng, Yuanli Zhen, Chiho Kim, Zhengshuai Liu, Jianwei Hao, Heping Deng, Hejun Deng i in. "Abstract B023: Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA-mutated cancer". Molecular Cancer Therapeutics 23, nr 6_Supplement (10.06.2024): B023. http://dx.doi.org/10.1158/1538-8514.synthleth24-b023.
Pełny tekst źródłaMilne, Julia V., Ebtihal Mustafa, Kenji Fujihara, Eric Kusnadi, Anna Trigos, Niko Thio, Maree Pechlivanis i in. "Abstract A006: Delineating functional drivers of esophageal adenocarcinoma to identify synthetic lethal interactions". Molecular Cancer Therapeutics 23, nr 6_Supplement (10.06.2024): A006. http://dx.doi.org/10.1158/1538-8514.synthleth24-a006.
Pełny tekst źródłaArafeh, Rand, Laura Chang, Lydia Sawyer, Helen Wang, James McFarland, Joshua Dempster, Peter DeWeirdt, John Doench i William C. Hahn. "Abstract B015: Combinatorial genetic screens to map synthetic lethal interactions and identify new cancer drug targets in KRAS mutant cancers". Molecular Cancer Therapeutics 23, nr 6_Supplement (10.06.2024): B015. http://dx.doi.org/10.1158/1538-8514.synthleth24-b015.
Pełny tekst źródłaYeh, Jen Jen. "Abstract IA011: Precision oncology approaches in pancreatic cancer". Cancer Research 82, nr 22_Supplement (15.11.2022): IA011. http://dx.doi.org/10.1158/1538-7445.panca22-ia011.
Pełny tekst źródłaMousseau, Richard J. "Abstract IA018: “Pursuing Wicozani for the Oceti Sakowin”: Reducing cancer disparities among AI/AN in the Great Plains". Cancer Epidemiology, Biomarkers & Prevention 32, nr 1_Supplement (1.01.2023): IA018. http://dx.doi.org/10.1158/1538-7755.disp22-ia018.
Pełny tekst źródłaLehman, Connie. "Abstract IA022: Imaging tools for DCIS: Past, present and future". Cancer Prevention Research 15, nr 12_Supplement_1 (1.12.2022): IA022. http://dx.doi.org/10.1158/1940-6215.dcis22-ia022.
Pełny tekst źródłaPolyak, Kornelia. "Abstract IA035: DCIS to IDC progression - a key step of immune escape". Cancer Prevention Research 15, nr 12_Supplement_1 (1.12.2022): IA035. http://dx.doi.org/10.1158/1940-6215.dcis22-ia035.
Pełny tekst źródłaBar-Sagi, Dafna. "Abstract IA21: Immune rewiring of mutant Ras tumors: Mechanisms and translational implications". Molecular Cancer Research 21, nr 5_Supplement (1.05.2023): IA21. http://dx.doi.org/10.1158/1557-3125.ras23-ia21.
Pełny tekst źródłaRobertson-Tessi, Mark, Joel Brown, Maria Poole, Kimberly Luddy, Andriy Marusyk, Jill Gallaher, Jeffrey West i in. "Abstract B006: Evolutionary Tumor Board: Implementing dynamic personalized therapy using evolutionary theory and mathematical modeling for clinical decision support". Cancer Research 82, nr 10_Supplement (15.05.2022): B006. http://dx.doi.org/10.1158/1538-7445.evodyn22-b006.
Pełny tekst źródłaAhmed, Atique U., Jack M. Shireman, Fatemeh Atash, Gina Lee, Eunus S. Ali, Miranda R. Saathoff, Cheol H. Park i in. "Abstract B034: Targeting cellular plasticity-driven metabolic adaptation to overcome chemoresistance in GBM". Cancer Research 82, nr 10_Supplement (15.05.2022): B034. http://dx.doi.org/10.1158/1538-7445.evodyn22-b034.
Pełny tekst źródłaChalloner, Benjamin R., Andrew Woolston, David Lau, Marta Buzzetti, Louise J. Barber, Tom Lund, Harold B. Sansano i in. "Abstract A002: Genetic and immune landscape evolution defines subtypes of MMR deficient colorectal cancer". Cancer Research 82, nr 10_Supplement (15.05.2022): A002. http://dx.doi.org/10.1158/1538-7445.evodyn22-a002.
Pełny tekst źródłaMadrigal, Ariel, Minjun Kim, Adrien Osakwe, Tianyuan Lu, Zohreh Mehrjoo, Elham Moslemi, Rick Farouni i in. "Abstract B011: An atlas of cellular heterogeneity in primary and metastatic renal cell carcinomas". Cancer Research 83, nr 16_Supplement (15.08.2023): B011. http://dx.doi.org/10.1158/1538-7445.kidney23-b011.
Pełny tekst źródłaBorges, Gabriel Alvares, Angelo Jose Guilatco, Christine M. Hachfeld, Ming Ruan, Sonya Royzenblat, Ming Xu, Claire M. Edwards i in. "Abstract B020: Pre-malignant plasma cells exhibit a senescence-like phenotype and accumulation of transposable elements". Cancer Research 83, nr 2_Supplement_1 (15.01.2023): B020. http://dx.doi.org/10.1158/1538-7445.agca22-b020.
Pełny tekst źródłaLan, Tuo, Mei Wang, AnnaLynn M. Williams, Matthew J. Ehrhardt, Emily R. Finch, Jennifer Q. Lanctot, Shu Jiang i in. "Abstract B004: Sugar Intake and premature aging in adult survivors of childhood cancer in the St. Jude Lifetime (SJLIFE) Cohort". Cancer Research 83, nr 2_Supplement_1 (15.01.2023): B004. http://dx.doi.org/10.1158/1538-7445.agca22-b004.
Pełny tekst źródła